CompletedNot Applicable

Comparison of the Efficacy of Two Different Suprascapular Nerve Block Techniques in Patients With Chronic Shoulder Pain

Turkey (Türkiye)80 participantsStarted 2021-06-01

Plain-language summary

The aim of this study is to compare the efficacy and safety of the suprascapular nerve block (SSNB) at the spinoglenoid notch with SSNB at the suprascapular notch, which is the most commonly used technique in patients with chronic shoulder pain.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 18 years old
✓. Shoulder pain that last more than 3 month
✓. Patients with a VAS value of ≥ 4 despite treatment (drugs used for analgesia, local injections and physiotherapy methods)
✓. Shoulder pain defined as non-specific shoulder pain, subacromial impingement syndrome, rotator cuff tendinopathy, adhesive capsulitis, non-traumatic instability, SLAP lesion, acromioclavicular pathology, and / or shoulder osteoarthritis.

Exclusion criteria

✕. A history of uncontrolled chronic diseases, e.g., malignant neoplasms, blood dyscrasia, and infection
✕. Previous surgery history at the affected shoulder
✕. Shoulder injection in the last 3 months before treatment
✕. The presence of cervical radiculopathy or myelopathy
✕. A previous fracture close to the shoulder region
✕. Presence of septic arthritis or local infection in the affected shoulder
✕. Presence of anaphylaxis against local anesthetics and / or corticosteroids
✕. Presence of a cardiac pacemaker

What they're measuring

Change of Shoulder Pain and Disability Index (SPADI)

Timeframe: Baseline and 1, 4, and 12 weeks after injection

Trial details

NCT IDNCT04938037

SponsorTC Erciyes University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-05

Results submitted2025-04-01

View on ClinicalTrials.gov More Chronic Shoulder Pain trials